載入...
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
BACKGROUND: The introduction of non–vitamin K antagonist oral anticoagulants has been a major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in clinical trials may not translate to routine practice. We aimed to evaluate the effectiveness and safety of dabigatran, ri...
Na minha lista:
| 發表在: | J Am Heart Assoc |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937291/ https://ncbi.nlm.nih.gov/pubmed/27412905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003725 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|